- Home
- ABEO vs PBPB Comparison
ABEO vs PBPB Comparison
Compare ABEO & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PBPB
- Stock Information
- Founded
- ABEO 1974
- PBPB 1977
- Country
- ABEO United States
- PBPB United States
- Employees
- ABEO N/A
- PBPB N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PBPB Restaurants
- Sector
- ABEO Health Care
- PBPB Consumer Discretionary
- Exchange
- ABEO Nasdaq
- PBPB Nasdaq
- Market Cap
- ABEO 332.0M
- PBPB 305.0M
- IPO Year
- ABEO 1980
- PBPB 2013
- Fundamental
- Price
- ABEO $6.26
- PBPB $12.55
- Analyst Decision
- ABEO Strong Buy
- PBPB Strong Buy
- Analyst Count
- ABEO 6
- PBPB 4
- Target Price
- ABEO $18.00
- PBPB $16.25
- AVG Volume (30 Days)
- ABEO 611.9K
- PBPB 279.5K
- Earning Date
- ABEO 08-19-2025
- PBPB 08-06-2025
- Dividend Yield
- ABEO N/A
- PBPB N/A
- EPS Growth
- ABEO N/A
- PBPB N/A
- EPS
- ABEO N/A
- PBPB 0.35
- Revenue
- ABEO N/A
- PBPB $469,138,000.00
- Revenue This Year
- ABEO N/A
- PBPB $4.74
- Revenue Next Year
- ABEO $322.37
- PBPB $4.48
- P/E Ratio
- ABEO N/A
- PBPB $36.21
- Revenue Growth
- ABEO N/A
- PBPB N/A
- 52 Week Low
- ABEO $3.93
- PBPB $6.69
- 52 Week High
- ABEO $7.32
- PBPB $13.67
- Technical
- Relative Strength Index (RSI)
- ABEO 47.50
- PBPB 55.33
- Support Level
- ABEO $6.18
- PBPB $10.83
- Resistance Level
- ABEO $6.94
- PBPB $13.67
- Average True Range (ATR)
- ABEO 0.27
- PBPB 0.54
- MACD
- ABEO -0.05
- PBPB -0.03
- Stochastic Oscillator
- ABEO 18.07
- PBPB 60.56
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.